Matthew Daubresse

1.6k total citations
25 papers, 1.2k citations indexed

About

Matthew Daubresse is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Anesthesiology and Pain Medicine. According to data from OpenAlex, Matthew Daubresse has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 8 papers in Pediatrics, Perinatology and Child Health and 6 papers in Anesthesiology and Pain Medicine. Recurrent topics in Matthew Daubresse's work include Opioid Use Disorder Treatment (13 papers), Pain Management and Opioid Use (6 papers) and Pharmaceutical Economics and Policy (6 papers). Matthew Daubresse is often cited by papers focused on Opioid Use Disorder Treatment (13 papers), Pain Management and Opioid Use (6 papers) and Pharmaceutical Economics and Policy (6 papers). Matthew Daubresse collaborates with scholars based in United States and New Zealand. Matthew Daubresse's co-authors include G. Caleb Alexander, Hsien‐Yen Chang, Stefan Kruszewski, Elizabeth A. Stuart, Lainie Rutkow, Randall S. Stafford, Nilay D. Shah, Daniel Webster, S Viswanathan and Brendan Saloner and has published in prestigious journals such as JAMA, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Matthew Daubresse

24 papers receiving 1.1k citations

Peers

Matthew Daubresse
Ajay Manhapra United States
Mark W. Parrino United States
Jordan R. Covvey United States
Aaron M. Gilson United States
Felicita David United States
Jason Hoppe United States
Andrew Kolodny United States
Matthew Daubresse
Citations per year, relative to Matthew Daubresse Matthew Daubresse (= 1×) peers Wei‐Hsuan Lo‐Ciganic

Countries citing papers authored by Matthew Daubresse

Since Specialization
Citations

This map shows the geographic impact of Matthew Daubresse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Daubresse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Daubresse more than expected).

Fields of papers citing papers by Matthew Daubresse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Daubresse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Daubresse. The network helps show where Matthew Daubresse may publish in the future.

Co-authorship network of co-authors of Matthew Daubresse

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Daubresse. A scholar is included among the top collaborators of Matthew Daubresse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Daubresse. Matthew Daubresse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daubresse, Matthew, G. Caleb Alexander, Deidra C. Crews, et al.. (2021). High-dose opioid utilization and mortality among individuals initiating hemodialysis. BMC Nephrology. 22(1). 65–65. 2 indexed citations
2.
Muzaale, Abimereki D., Matthew Daubresse, Sunjae Bae, et al.. (2020). Benzodiazepines, Codispensed Opioids, and Mortality among Patients Initiating Long-Term In-Center Hemodialysis. Clinical Journal of the American Society of Nephrology. 15(6). 794–804. 12 indexed citations
3.
Segal, Jodi B, Matthew Daubresse, Chia‐Ying Lee, et al.. (2020). Determinants of Generic Drug Substitution in the United States. Therapeutic Innovation & Regulatory Science. 54(1). 151–157. 9 indexed citations
4.
Chang, Hsien‐Yen, Matthew Daubresse, Brendan Saloner, & G. Caleb Alexander. (2019). Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use Disorder. Medical Care. 57(9). 667–672. 5 indexed citations
5.
McAdams‐DeMarco, Mara, Matthew Daubresse, Sunjae Bae, et al.. (2018). Dementia, Alzheimer’s Disease, and Mortality after Hemodialysis Initiation. Clinical Journal of the American Society of Nephrology. 13(9). 1339–1347. 59 indexed citations
6.
Daubresse, Matthew, G. Caleb Alexander, Deidra C. Crews, Dorry L. Segev, & Mara McAdams‐DeMarco. (2018). Trends in Opioid Prescribing Among Hemodialysis Patients, 2007–2014. American Journal of Nephrology. 49(1). 20–31. 11 indexed citations
7.
Rutkow, Lainie, et al.. (2016). EFFECT OF A “PILL MILL” LAW ON OPIOID PRESCRIBING AND UTILIZATION: THE CASE OF TEXAS. Value in Health. 19(3). A256–A256. 1 indexed citations
8.
Chang, Hsien‐Yen, Lainie Rutkow, Matthew Daubresse, et al.. (2016). Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis. Drug and Alcohol Dependence. 165. 1–8. 94 indexed citations
9.
Daubresse, Matthew, Martin Andersen, Kevin R. Riggs, & G. Caleb Alexander. (2016). Effect of Prescription Drug Coupons on Statin Utilization and Expenditures: A Retrospective Cohort Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(1). 12–24. 16 indexed citations
10.
Daubresse, Matthew, Susan Hutfless, Yoonsang Kim, et al.. (2015). Effect of Direct-to-Consumer Advertising on Asthma Medication Sales and Healthcare Use. American Journal of Respiratory and Critical Care Medicine. 192(1). 40–46. 24 indexed citations
11.
Rutkow, Lainie, Hsien‐Yen Chang, Matthew Daubresse, et al.. (2015). Effect of a “pill mill” law on opioid prescribing and utilization: The case of Texas. Drug and Alcohol Dependence. 159. 190–197. 62 indexed citations
12.
Hampton, Lee M., Matthew Daubresse, Hsien‐Yen Chang, G. Caleb Alexander, & Daniel S. Budnitz. (2015). Emergency Department Visits by Children and Adolescents for Antipsychotic Drug Adverse Events. JAMA Psychiatry. 72(3). 292–292. 5 indexed citations
13.
Daubresse, Matthew, et al.. (2015). National Trends in the Ambulatory Treatment of Hypertension in the United States, 1997-2012. PLoS ONE. 10(3). e0119292–e0119292. 19 indexed citations
14.
Rutkow, Lainie, Hsien‐Yen Chang, Matthew Daubresse, et al.. (2015). Effect of Florida’s Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. JAMA Internal Medicine. 175(10). 1642–1642. 206 indexed citations
15.
Daubresse, Matthew & G. Caleb Alexander. (2014). The uphill battle facing antiobesity drugs. International Journal of Obesity. 39(3). 377–378. 12 indexed citations
16.
Chang, Hsien‐Yen, Matthew Daubresse, Stefan Kruszewski, & G. Caleb Alexander. (2014). Prevalence and treatment of pain in EDs in the United States, 2000 to 2010. The American Journal of Emergency Medicine. 32(5). 421–431. 129 indexed citations
17.
Hampton, Lee M., Matthew Daubresse, Hsien‐Yen Chang, G. Caleb Alexander, & Daniel S. Budnitz. (2014). Emergency Department Visits by Adults for Psychiatric Medication Adverse Events. JAMA Psychiatry. 71(9). 1006–1006. 102 indexed citations
18.
Daubresse, Matthew, Hsien‐Yen Chang, S Viswanathan, et al.. (2013). Ambulatory Diagnosis and Treatment of Nonmalignant Pain in the United States, 2000–2010. Medical Care. 51(10). 870–878. 242 indexed citations
19.
Daubresse, Matthew, S Viswanathan, Yifan Yu, et al.. (2013). Ambulatory diagnosis and treatment of non-malignant pain in the United States, 2000–2010. Value in Health. 16(3). A127–A127. 13 indexed citations
20.
Fain, Kevin M., Matthew Daubresse, & G. Caleb Alexander. (2013). The Food and Drug Administration Amendments Act and Postmarketing Commitments. JAMA. 310(2). 202–202. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026